» Articles » PMID: 29296105

Establishment and Evaluation of Four Different Types of Patient-derived Xenograft Models

Abstract

Background: Patient-derived xenografts (PDX) have a biologically stable in tumor architecture, drug responsiveness, mutational status and global gene-expression patterns. Numerous PDX models have been established to date, however their thorough characterization regarding the tumor formation and rates of tumor growth in the established models remains a challenging task. Our study aimed to provide more detailed information for establishing the PDX models successfully and effectively.

Methods: We transplanted four different types of solid tumors from 108 Chinese patients, including 21 glioblastoma (GBM), 11 lung cancers (LC), 54 gastric cancers (GC) and 21 colorectal cancers (CRC), and took tumor tissues passaged for three successive generations. Here we report the rate of tumor formation, tumor-forming times, tumor growth curves and mortality of mice in PDX model. We also report H&E staining and immunohistochemistry for HLA-A, CD45, Ki67, GFAP, and CEA protein expression between patient cancer tissues and PDX models.

Results: Tumor formation rate increased significantly in subsequent tumor generations. Also, the survival rates of GC and CRC were remarkably higher than GBM and LC. As for the time required for the formation of tumors, which reflects the tumor growth rate, indicated that tumor growth rate always increased as the generation number increased. The tumor growth curves also illustrate this law. Similarly, the survival rate of PDX mice gradually improved with the increased generation number in GC and CRC. And generally, there was more proliferation (Ki67+) in the PDX models than in the patient tumors, which was in accordance with the results of tumor growth rate. The histological findings confirm similar histological architecture and degrees of differentiation between patient cancer tissues and PDX models with statistical analysis by GraphPad Prism 5.0.

Conclusion: We established four different types of PDX models successfully, and our results add to the current understanding of the establishment of PDX models and may contribute to the extension of application of different types of PDX models.

Citing Articles

Establishment and Clinical Significance of the Patient-Derived Xenograft Model of Colorectal Cancer.

Zhang L, Li Y, Yao L, He R, Wu J Cureus. 2024; 16(10):e71116.

PMID: 39525113 PMC: 11544153. DOI: 10.7759/cureus.71116.


Direct Implantation of Patient Brain Tumor Cells into Matching Locations in Mouse Brains for Patient-Derived Orthotopic Xenograft Model Development.

Qi L, Baxter P, Kogiso M, Zhang H, Braun F, Lindsay H Cancers (Basel). 2024; 16(9).

PMID: 38730671 PMC: 11083000. DOI: 10.3390/cancers16091716.


Comparative RNA-Seq Analysis Revealed Tissue-Specific Splicing Variations during the Generation of the PDX Model.

Lee E, Noh S, Choi H, Kim M, Kim S, Seo Y Int J Mol Sci. 2023; 24(23).

PMID: 38069324 PMC: 10707456. DOI: 10.3390/ijms242317001.


Molecular markers predicting the progression and prognosis of human papillomavirus-induced cervical lesions to cervical cancer.

Amin F, Naher Z, Shaik Syed Ali P J Cancer Res Clin Oncol. 2023; 149(10):8077-8086.

PMID: 37000261 DOI: 10.1007/s00432-023-04710-5.


The development of a rapid patient-derived xenograft model to predict chemotherapeutic drug sensitivity/resistance in malignant glial tumors.

Charbonneau M, Harper K, Brochu-Gaudreau K, Perreault A, Roy L, Lucien F Neuro Oncol. 2023; 25(9):1605-1616.

PMID: 36821432 PMC: 10479744. DOI: 10.1093/neuonc/noad047.


References
1.
Edwards E, Geng L, Tan J, Onishko H, Donnelly E, Hallahan D . Phosphatidylinositol 3-kinase/Akt signaling in the response of vascular endothelium to ionizing radiation. Cancer Res. 2002; 62(16):4671-7. View

2.
Herrmann D, Conway J, Vennin C, Magenau A, Hughes W, Morton J . Three-dimensional cancer models mimic cell-matrix interactions in the tumour microenvironment. Carcinogenesis. 2014; 35(8):1671-9. DOI: 10.1093/carcin/bgu108. View

3.
Garcia-Barros M, Thin T, Maj J, Cordon-Cardo C, Haimovitz-Friedman A, Fuks Z . Impact of stromal sensitivity on radiation response of tumors implanted in SCID hosts revisited. Cancer Res. 2010; 70(20):8179-86. PMC: 2976483. DOI: 10.1158/0008-5472.CAN-10-1871. View

4.
Rubio-Viqueira B, Jimeno A, Cusatis G, Zhang X, Iacobuzio-Donahue C, Karikari C . An in vivo platform for translational drug development in pancreatic cancer. Clin Cancer Res. 2006; 12(15):4652-61. DOI: 10.1158/1078-0432.CCR-06-0113. View

5.
Garcia-Barros M, Paris F, Cordon-Cardo C, Lyden D, Rafii S, Haimovitz-Friedman A . Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science. 2003; 300(5622):1155-9. DOI: 10.1126/science.1082504. View